FairValueLabs Valuation System Value Investment
A

Agilent Technologies, Inc. (A) Stock Analysis — Fair Value, Risk & Moat Rating

NYQ · Healthcare · Diagnostics & Research

$120.47 Fairly Valued -1.62 (-1.3%) As of Apr 22, 2026 Not a buy/sell recommendation. See disclaimer.
Overall Verdict Caution
4.73
Altman Z-ScoreSafe Zone
$111.19
Fair ValueFairly Valued (-8.3%)
3.4
Moat RatingNarrow moat
TL;DR · Audit Summary

Is Agilent Technologies, Inc. a safe investment right now?

Agilent Technologies, Inc.'s Altman Z-Score of 4.73 places it in the safe zone. Our fair value estimate is $111.19 (Fairly Valued). Moat rating: 3.4/5 stars.

Price Chart · A
Section 01 · Financial Health

Could Agilent Technologies, Inc. go bankrupt? Altman Z-Score analysis

4.73

Z-Score of 4.73 is above 3.0, indicating the company is financially healthy by this metric.

  • Below 1.8 — Distress Zone (high bankruptcy risk)
  • 1.8 to 3.0 — Gray Zone (elevated uncertainty)
  • Above 3.0 — Safe Zone (financially healthy)

What drives A's Z-Score?

Altman Z-Score components for A
ComponentFormulaValueWeightContribution
A · Working Capital / Total AssetsWC / TA0.17661.20.21
B · Retained Earnings / Total AssetsRE / TA0.10911.40.15
C · EBIT / Total AssetsEBIT / TA0.12163.30.4
D · Market Cap / Total LiabilitiesMCap / TL5.69220.63.42
E · Revenue / Total AssetsRev / TA0.54591.00.55

How has A's financial health changed over time?

3.0 Safe1.8 Distress0.01.63.24.86.52022202320242025
A Z-Score history
YearZ-ScoreZone
20225.32Safe
20235.62Safe
20244.73Safe
20254.73Safe

Source: Calculated from A's latest 10-K filing on SEC EDGAR.

Section 02 · Fair Value Estimate

What is Agilent Technologies, Inc. actually worth?

FVL Fair Value$111.19
vs
Market Price$120.47
Fairly Valued -8.3% Stock trades 8.3% above our estimated fair value of $111.19.

How we calculated this

FVL Valuation Model
InputValueSource
Predicted EPS (α)$4.92Proprietary blend of reported actuals (1Q actual) + analyst consensus, weighted by α
Last Year EPS$4.57Annual report (SEC EDGAR)
Analyst Consensus EPS (This Year)$5.9716 analysts consensus
Trailing P/E26.6xCurrent market pricing
Fair P/E (β discount)22.6xTrailing PE adjusted by value discount factor β, hard-capped
Earnings Trend (γ)GrowingDirectional signal: predicted vs trailing EPS

Wall Street Reference: Analyst consensus target price is $160.69 (16 analysts). This is shown for reference only and is not used in our valuation model.

Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.

Section 03 · Competitive Moat

Does Agilent Technologies, Inc. have a durable competitive advantage?

★★★☆☆
Narrow moat

Moat rating: 3.4/5.

What makes up A's moat score?

ROIC Stability

★★★★☆

ROIC variability over the past decade. Score: 4/5.

Gross Margin Trend

★★★☆☆

Gross margin trajectory over the past decade. Score: 3/5.

Switching Costs

★★★☆☆

Estimated customer lock-in based on margin level. Score: 3/5.

How stable is A's return on invested capital?

0%-5%2%10%17%25%2022202320242025
A ROIC history
YearROICTrend
202219.7%
202316.7%Declining
202417.4%Stable
202515.3%Declining

Source: ROIC calculated from SEC EDGAR filings.

Section 04 · Dividend Safety

Is Agilent Technologies, Inc.'s dividend safe?

A Dividend Safety Grade
Yield0.8%
Payout Ratio22.1%
Consecutive Years16
5Y Growth Rate-8.1%

Can Agilent Technologies, Inc. afford its dividend?

Payout ratio is 22.1%. FCF covers the dividend 4.1x. 16 consecutive years of payments.

Section 05 · Financial Summary

Agilent Technologies, Inc.'s key financial metrics

A financial summary
MetricLatest1Y Ago3Y AgoTrend
Revenue $6.9B $6.5B $6.8B Stable
Net Income $1.3B $1.3B $1.3B Stable
Free Cash Flow $1.2B $1.4B $1.0B Rising
Gross Margin 52.4% 54.3% 54.4% Stable
Section 06 · Lab Signals

Recent events that affect our A analysis

EARNINGS

A earnings report scheduled

Lab Impact

Upcoming report. Consensus EPS estimate: $1.41. Revenue estimate: $1.80B. Our current Fair Value: $111.19 — a significant beat or miss could shift this estimate.

ANALYST

A analyst consensus: 78% bullish (14 of 18 analysts)

Lab Impact

4 Strong Buy, 10 Buy, 4 Hold, 0 Sell, 0 Strong Sell. Consensus target: $160.69 (33.4% upside). Compare with our independent Fair Value: $111.19.

FILING

A filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

A paid $0.2550/share dividend

Lab Impact

Dividend Safety Grade: A. Payout ratio: 22.1%.

FILING

A filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

A filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

A filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

EARNINGS

A missed EPS estimates by 0.6%

Lab Impact

Reported EPS: $1.36 vs estimate $1.37. Our Fair Value of $111.19 may face downward pressure if the trend continues.

FILING

A filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

A paid $0.2550/share dividend

Lab Impact

Dividend Safety Grade: A. Payout ratio: 22.1%.

FILING

A filed annual report (10-K)

Lab Impact

Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →

EARNINGS

A beat EPS estimates by 0.4%

Lab Impact

Reported EPS: $1.59 vs estimate $1.58. Earnings strength supports our Fair Value of $111.19 (7.7% below current price).

FILING

A filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

A filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

A paid $0.2480/share dividend

Lab Impact

Dividend Safety Grade: A. Payout ratio: 22.1%.

FILING

A filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

EARNINGS

A beat EPS estimates by 0.2%

Lab Impact

Reported EPS: $1.37 vs estimate $1.37. Earnings strength supports our Fair Value of $111.19 (7.7% below current price).

FILING

A filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

A filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

A paid $0.2480/share dividend

Lab Impact

Dividend Safety Grade: A. Payout ratio: 22.1%.

FILING

A filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

EARNINGS

A beat EPS estimates by 3.6%

Lab Impact

Reported EPS: $1.31 vs estimate $1.26. Earnings strength supports our Fair Value of $111.19 (7.7% below current price).

FILING

A filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

A filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

A filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

A filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

A paid $0.2480/share dividend

Lab Impact

Dividend Safety Grade: A. Payout ratio: 22.1%.

FILING

A filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

A filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

A filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

EARNINGS

A beat EPS estimates by 3.0%

Lab Impact

Reported EPS: $1.31 vs estimate $1.27. Earnings strength supports our Fair Value of $111.19 (7.7% below current price).

FILING

A filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

Section 07 · FAQ

Common questions about Agilent Technologies, Inc.

What is Agilent Technologies, Inc. stock price today?

Agilent Technologies, Inc. (A) stock price is $120.47 as of the latest market close, traded on the NYSE exchange.

What does Agilent Technologies, Inc. do?

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets.

What is Agilent Technologies, Inc. market cap?

Agilent Technologies, Inc. has a market capitalization of $34.07B, classifying it as a large-cap stock in the Healthcare sector.

What sector and industry is A in?

Agilent Technologies, Inc. operates in the Healthcare sector, specifically within the Diagnostics & Research industry. It trades on the NYSE under the ticker symbol A.

Is A stock overvalued or undervalued?

Based on our valuation model, Agilent Technologies, Inc. trades 8.3% above our fair value estimate — potentially overvalued.

  • FairValueLabs Fair Value: $111.19
  • Current Price: $120.47
  • Valuation Zone: Fairly Valued
What is A stock forecast and analyst target price?

Based on 16 Wall Street analysts, the consensus price target for Agilent Technologies, Inc. is $160.69, implying upside of 33.4% from the current price.

  • Analyst High Target: $185.00
  • Analyst Low Target: $140.00

Note: Analyst targets are shown for reference and are not used in our valuation model.

Is Agilent Technologies, Inc. revenue and earnings growing?

Here are the analyst consensus growth estimates for Agilent Technologies, Inc.:

  • Revenue growth (current year est.): 6.4%
  • EPS growth (current year est.): 6.8%
  • Revenue growth (next year est.): 6.1%
  • EPS growth (next year est.): 10.3%
What are Agilent Technologies, Inc.'s key financial metrics?
MetricLatestTrend
Revenue$6.9BStable
Net Income$1.3BStable
Free Cash Flow$1.2BRising
Gross Margin52.4%Stable
What is A's P/E ratio?

The price-to-earnings ratio measures how much investors pay per dollar of earnings:

  • Trailing P/E (last 12 months): 26.6x
  • Forward P/E (next 12 months est.): 18.3x
  • FairValueLabs Fair P/E: 22.6x
How volatile is A stock?

Agilent Technologies, Inc. has a beta of 1.30, meaning it is somewhat more volatile than the broader market. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.

How much cash and debt does Agilent Technologies, Inc. have?

Agilent Technologies, Inc.'s balance sheet shows:

  • Total Cash: $1.76B
  • Total Debt: $3.55B
  • Net Cash Position: $-1.79B

A positive net cash position means the company holds more cash than debt, reducing financial risk.

What is Agilent Technologies, Inc.'s free cash flow?

Agilent Technologies, Inc. generated $855.9M in trailing twelve-month free cash flow (from $1.40B in operating cash flow). Free cash flow represents the cash available for dividends, buybacks, and debt reduction after all capital expenditures.

Does Agilent Technologies, Inc. pay a dividend, and is it safe?

Yes, Agilent Technologies, Inc. pays a regular dividend. Here are the key metrics:

  • Dividend Yield: 0.8%
  • Payout Ratio: 22.1%
  • Consecutive Years Paid: 16
  • 5-Year Dividend Growth: -8.1%
  • FairValueLabs Safety Grade: A
Is Agilent Technologies, Inc. at risk of going bankrupt?

Agilent Technologies, Inc.'s Altman Z-Score is 4.73, placing it in the safe zone (above 3.0) — bankruptcy risk is low. The Z-Score uses five balance sheet ratios to predict bankruptcy probability within two years.

Does Agilent Technologies, Inc. have a durable competitive advantage?

Agilent Technologies, Inc. scores 3.4/5 stars (Narrow moat) in our moat analysis:

  • ROIC Stability: 4/5
  • Gross Margin Trend: 3/5
  • Switching Costs: 3/5

A score above 3.5 suggests meaningful pricing power and a defensible market position.

What is A's return on equity (ROE)?

Agilent Technologies, Inc.'s return on equity is 20.0%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.

How do I buy A stock?

A shares can be purchased through any brokerage account that provides access to the NYSE. Common steps:

  1. Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
  2. Search for ticker symbol A
  3. Place a market or limit order for your desired number of shares

This is not investment advice. Always do your own research before buying any stock.

Is A a value stock or speculative?

FairValueLabs classifies Agilent Technologies, Inc. as Value Investment. It exhibits consistent profitability, reasonable valuation, and financial stability — characteristics of a traditional value investment.

Who is the CEO of Agilent Technologies, Inc.?

The current CEO of Agilent Technologies, Inc. is Mr. Padraig McDonnell.

What is A's earnings per share (EPS)?

Earnings per share measures the company's profit allocated to each outstanding share:

  • Trailing EPS (last 12 months): $4.53
  • Forward EPS (next 12 months est.): $6.58
  • Analyst consensus EPS (this year): $5.97
  • Analyst consensus EPS (next year): $6.58

FairValueLabs Disclaimer

All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.

This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.

Last updated: Apr 22, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.

A analysis methodology: How we calculate fair value, Z-Scores, and moat ratings